Mejri Islam, Boubaker Nouha, Znegui Tasnim, Daboussi Selsabil, Aichaouia Chiraz, Mhamdi Samira, Moatemri Zied
Pneumology Department, Military Hospital, Tunis, Tunisia.
Eur J Case Rep Intern Med. 2022 Aug 1;9(8):003475. doi: 10.12890/2022_003475. eCollection 2022.
Massive haemoptysis is a rare symptom ofcoronavirus disease 2019 (COVID-19). Management can be very challenging due to the lack of clear recommendations.
We report a case of massive recurrent haemoptysis in a young patient who tested positive for COVID-19 with successful management using endovascular embolization.
Life-threatening massive haemoptysis has rarely been reported as the only manifestation of COVID-19. Embolisation was the therapeutic option chosen to manage this emergency.
Haemoptysis is a rare atypical presentation that can reveal COVID-19, highlighting the complexity of its pathogenesis.Atypical manifestations should raise suspicion for COVID-19.In this patient with COVID-19, life-threatening massive haemoptysis was successfully treated with endovascular embolisation.
大咯血是2019冠状病毒病（COVID-19）的一种罕见症状。由于缺乏明确的推荐意见，其治疗可能极具挑战性。
我们报告一例年轻患者反复发生大咯血，该患者COVID-19检测呈阳性，通过血管内栓塞成功治疗。
危及生命的大咯血作为COVID-19的唯一表现鲜有报道。栓塞是用于处理这一紧急情况的治疗选择。
咯血是一种可揭示COVID-19的罕见非典型表现，凸显了其发病机制的复杂性。非典型表现应引起对COVID-19的怀疑。在该COVID-19患者中，危及生命的大咯血通过血管内栓塞成功治疗。
